Our Ambition

OUR AMBITION FOR THE NEXT FIVE YEARS IS TO:

TARGET

greater research investment into the poorest prognosis cancers, which are poorly served by current treatments ACCELERATE the translation of lab discoveries into new effective treatments for people with cancer

FACILITATE greater collaboration between scientists and clinicians across Ireland and Internationally BUILD expertise and capacity to move from bench to bedside, and from cancer patients back to the laboratory FOCUS on keeping the patient at the centre of all of our activities

This research strategy is building on Breakthrough Cancer Research’s a decade of success, facilitating patient-focused research. As we move forward, we are determined to facilitate advances in knowledge of the poorest prognosis cancers through research – to improve prevention, diagnosis and treatment, so that more people survive. Our ambition, as we work with a growing number of researchers, clinicians, patients, industry and policy makers, both nationally and internationally is to see a doubling in the survival of these poorest prognosis cancers over the next twenty years. We believe that this is achievable through research DR. FRANCES DRUMMOND

RESEARCH MANAGER